ascorbic-acid and Tachycardia

ascorbic-acid has been researched along with Tachycardia* in 6 studies

Trials

1 trial(s) available for ascorbic-acid and Tachycardia

ArticleYear
NaHCO
    Tropical animal health and production, 2022, Mar-01, Volume: 54, Issue:2

    The study aimed to investigate if vegetable-based high-energy mash diets supplemented with NaHCO

    Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Arginine; Ascorbic Acid; Chickens; Diet; Dietary Supplements; Polycythemia; Tachycardia; Vegetables

2022

Other Studies

5 other study(ies) available for ascorbic-acid and Tachycardia

ArticleYear
C for colored urine: acute hemolysis induced by high-dose ascorbic acid.
    Clinical toxicology (Philadelphia, Pa.), 2014, Volume: 52, Issue:9

    Topics: Acute Disease; Ascorbic Acid; Dose-Response Relationship, Drug; Erythrocytes; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Infant; Male; Tachycardia

2014
Enhancement of glutathione cardioprotection by ascorbic acid in myocardial reperfusion injury.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 301, Issue:2

    The present experiment determined the effects of glutathione and ascorbic acid, the two most important hydrophilic antioxidants, on myocardial ischemia-reperfusion injury and evaluated their relative therapeutic values. Isolated rat hearts were subjected to ischemia (30 min) and reperfusion (120 min) and treated with ascorbic acid, glutathione monoethyl ester (GSHme), or their combination at the onset of reperfusion. Administration of 1 mM GSHme alone, but not 1 mM ascorbic acid alone, significantly attenuated postischemic injury (P < 0.05 versus vehicle). Most interestingly, coadministration of ascorbic acid with GSHme markedly enhanced the protective effects of GSHme (P < 0.01 versus vehicle). The protection exerted by the combination of GSHme and ascorbic acid at 1 mM each was significantly greater than that observed with 1 mM GSHme alone (P < 0.05). Moreover, treatment with GSHme alone or GSHme plus ascorbic acid markedly reduced myocardial nitrotyrosine levels, suggesting that these treatments attenuated myocardial peroxynitrite formation. These results demonstrated that 1) GSHme, but not ascorbic acid, exerted protective effects against ischemia-reperfusion injury; and 2) the protective effects of GSHme were further enhanced by coadministration with ascorbic acid, suggesting a synergistic effect between GSHme and ascorbic acid.

    Topics: Animals; Antioxidants; Ascorbic Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Glutathione; Heart; Heart Rate; Incidence; Lipid Peroxidation; Myocardial Reperfusion Injury; Myocardium; Protective Agents; Rats; Reperfusion Injury; Tachycardia; Tyrosine; Ventricular Fibrillation

2002
[Intoxication by hydrogen sulfide in a natural gas refinery].
    European journal of toxicology and environmental hygiene. Journal europeen de toxicologie, 1974, Volume: 7, Issue:1

    Topics: Accidents, Occupational; Ascorbic Acid; Coma; Cyanosis; Environmental Exposure; Euphoria; Gastrointestinal Diseases; Humans; Hydrogen Sulfide; Nausea; Occupational Diseases; Oxygen Inhalation Therapy; Petroleum; Respiratory Tract Diseases; Tachycardia

1974
[Thyrotoxic crisis: symptoms and therapy (author's transl)].
    Medizinische Klinik, 1973, Dec-21, Volume: 68, Issue:51

    Topics: Adult; Aged; Ascorbic Acid; Body Temperature; Contrast Media; Female; First Aid; Germany, West; Humans; Iodides; Iodine; Male; Methimazole; Middle Aged; Phenobarbital; Prednisolone; Tachycardia; Thyroid Crisis; Triiodothyronine

1973
[ENDOCARDIAL FIBROELASTOSIS IN CHILDHOOD].
    Cardiologia pratica, 1963, Volume: 14

    Topics: Adrenal Cortex Hormones; Ascorbic Acid; Balsams; Central Nervous System Stimulants; Digitalis; Digitalis Glycosides; Electrocardiography; Endocardial Fibroelastosis; Humans; Infant; Liver Extracts; Oxygen Inhalation Therapy; Pathology; Penicillins; Radiography, Thoracic; Streptomycin; Tachycardia

1963